EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pre-, pro-, syn-, and Postbiotics in Infant Formulas: What Are the Immune Benefits for Infants?

Anaïs Lemoine iD, Patrick Tounian iD, Karine Adel-Patient, Muriel Thomas iD

Nutrients · 2023

DOI: 10.3390/nu15051231 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2023. Verfasst von Anaïs Lemoine und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Nutrition and Gastroenterology, Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, F-75012 Paris, France. Hauptthemen laut MEDLINE: Infant Formula, Probiotics. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The first objective of infant formulas is to ensure the healthy growth of neonates and infants, as the sole complete food source during the first months of life when a child cannot be breastfed. Beyond this nutritional aspect, infant nutrition companies also try to mimic breast milk in its unique immuno-modulating properties. Numerous studies have demonstrated that the intestinal microbiota under the influence of diet shapes the maturation of the immune system and influences the risk of atopic diseases in infants. A new challenge for dairy industries is, therefore, to develop infant formulas inducing the maturation of immunity and the microbiota that can be observed in breastfed delivered vaginally, representing reference infants. Streptococcus thermophilus, Lactobacillus reuteri DSM 17938, Bifidobacterium breve (BC50), Bifidobacterium lactis Bb12, Lactobacillus fermentum (CECT5716), and Lactobacillus rhamnosus GG (LGG) are some of the probiotics added to infant formula, according to a literature review of the past 10 years. The most frequently used prebiotics in published clinical trials are fructo-oligosaccharides (FOSs), galacto-oligosaccharides (GOSs), and human milk oligosaccharides (HMOs). This review sums up the expected benefits and effects for infants of pre-, pro-, syn-, and postbiotics added to infant formula regarding the microbiota, immunity, and allergies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infant FormulaProbioticsInfant, NewbornFemaleChildHumansInfantBreast FeedingMilk, HumanOligosaccharides

Stichwörter der Autor:innen

atopyimmunityinfant formulamicrobiotapostbioticprebioticprobioticsynbiotic

Substanzen

Oligosaccharides

Autor:innen und Institutionen

  • Pediatric Nutrition and Gastroenterology, Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, F-75012 Paris, France.
  • UMR1319, Micalis Institute, INRAE, AgroParisTech, Université Paris-Saclay, F-78350 Jouy-en-Josas, France.
  • Paris Center for Microbiome Medicine (PaCeMM) FHU, AP-HP, F-75571 Paris, France.
  • Département Médicaments et Technologies pour la Santé (DMTS), SPI/Laboratoire d'Immuno-Allergie Alimentaire, Université Paris-Saclay, CEA, INRAe, F-91190 Gif-sur-Yvette, France.

ORCID-Profile: Anaïs Lemoine, Patrick Tounian, Muriel Thomas

Zitieren

APA

Lemoine, A., Tounian, P., Adel-Patient, K., & Thomas, M. (2023). Pre-, pro-, syn-, and Postbiotics in Infant Formulas: What Are the Immune Benefits for Infants?. Nutrients. https://doi.org/10.3390/nu15051231

Vancouver

Lemoine A, Tounian P, Adel-Patient K, Thomas M. Pre-, pro-, syn-, and Postbiotics in Infant Formulas: What Are the Immune Benefits for Infants?. Nutrients. 2023. doi:10.3390/nu15051231

BibTeX
@article{Lemoine2023,
  author = {Lemoine, Anaïs and Tounian, Patrick and Adel-Patient, Karine and Thomas, Muriel},
  title = {Pre-, pro-, syn-, and Postbiotics in Infant Formulas: What Are the Immune Benefits for Infants?},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15051231}
}
Kostenlos starten →